To access this element change to forms mode OFF
Grant Award View - GA8844-V1
The development of industry-independent cancer clinical trial protocols.
GA ID:
GA8844-V1
Agency:
Cancer Australia
Approval Date:
29-Jun-2018
Variation Publish Date:
13-Dec-2021
Variation Date:
24-Jun-2021
Category:
Cancer
Grant Term:
1-Jul-2018 to 1-Mar-2022
Value (AUD):
$1,750,000.00
(GST inclusive where applicable)
Varies:
GA8844
- The development of industry-independent cancer clinical trial protocols.
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 18/19 Improved cancer control
Grant Program:
Support for Cancer Clinical Trials Program
Grant Activity:
The development of industry-independent cancer clinical trial protocols.
Purpose:
Clinical trials benefit the community by improving the survival of people affected by cancer, and contribute to a reduction in premature death and disability. Clinical trials are fundamental to establishing if new cancer treatments, diagnostic tests or preventive interventions are effective and they help generate evidence for best-practice cancer care.
GO ID:
GO Title:
Support for Cancer Clinical Trials Program
Internal Reference ID:
Support for Cancer Clinical Trials Program
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
The University of Melbourne acting for the Australia and New Zealand Sarcoma Association
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
The University of Melbourne
Town/City:
Melbourne
Postcode:
3010
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
National
Postcode:
Multiple
Country:
AUSTRALIA